PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5877.12M
Enterprise Value 3809.47M
Trailing P/E N/A
Forward P/E 1-12.22
PEG Ratio (5 yr expected) 1-0.29
Price/Sales (ttm)11.59
Price/Book (mrq)9.25
Enterprise Value/Revenue 310.69
Enterprise Value/EBITDA 6-9.04

Trading Information

Stock Price History

Beta (3Y Monthly) 0.82
52-Week Change 340.15%
S&P500 52-Week Change 31.11%
52 Week High 37.84
52 Week Low 33.90
50-Day Moving Average 35.66
200-Day Moving Average 36.75

Share Statistics

Avg Vol (3 month) 31.81M
Avg Vol (10 day) 31.35M
Shares Outstanding 5152.68M
Float 141.14M
% Held by Insiders 14.18%
% Held by Institutions 174.12%
Shares Short (Jul 15, 2019) 423.15M
Short Ratio (Jul 15, 2019) 412.07
Short % of Float (Jul 15, 2019) 416.43%
Short % of Shares Outstanding (Jul 15, 2019) 415.16%
Shares Short (prior month Jun 14, 2019) 421.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -143.62%
Operating Margin (ttm)-127.86%

Management Effectiveness

Return on Assets (ttm)-35.32%
Return on Equity (ttm)-110.03%

Income Statement

Revenue (ttm)75.69M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)25.1M
EBITDA -89.56M
Net Income Avi to Common (ttm)-108.71M
Diluted EPS (ttm)-0.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.87M
Total Cash Per Share (mrq)0.54
Total Debt (mrq)63.32M
Total Debt/Equity (mrq)66.76
Current Ratio (mrq)2.50
Book Value Per Share (mrq)0.62

Cash Flow Statement

Operating Cash Flow (ttm)-72.97M
Levered Free Cash Flow (ttm)-25.19M